XOMA Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.02%171.710.7%$1109.33m
AZNAstraZeneca Plc 0.80%58.431.2%$906.82m
PFEPfizer Inc. 0.45%41.660.9%$889.02m
MRKMerck & Co., Inc. 1.13%77.400.7%$788.50m
LLYEli Lilly & Co. 1.99%243.231.1%$742.81m
ABBVAbbVie, Inc. 0.55%118.191.9%$706.92m
BMYBristol-Myers Squibb Co. 0.54%68.331.0%$596.29m
GSKGlaxoSmithKline Plc 0.64%39.480.2%$189.67m
NVSNovartis AG 0.26%91.320.2%$150.04m
CERECerevel Therapeutics Holdings, Inc. -1.72%24.560.2%$149.80m
NRXPNRX Pharmaceuticals, Inc. 40.77%23.160.0%$141.21m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.04%125.430.0%$92.93m
VTRSViatris, Inc. 0.25%13.890.0%$87.16m
OGNOrganon & Co. -3.69%29.780.0%$83.66m
RPRXRoyalty Pharma Plc -0.52%40.150.2%$77.04m

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.